PMVP — PMV PHARMACEUTICALS INC

Ownership history in Rangeley Capital, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which Rangeley Capital, LLC reported a position in PMV PHARMACEUTICALS INC (PMVP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.06% (2025 Q3)
Avg. % of fund
0.05%
First filed
2025 Q3
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 45,500 — 0% 0.05% $57K $1.25
2025 Q3 INITIATED 45,500 — — 0.06% $64K $1.40
% of Fund (quarterly)    PMVP price (monthly, adj. close)

Other funds also holding PMVP

As of 2025 Q4 — sorted by position size

BML Capital Management, LLC 3Y 5.72% Stonepine Capital Management, LLC 3Y 7Y 1.05% Euclidean Capital LLC 3Y 0.89% Aldebaran Capital, LLC 3Y 0.54% Sio Capital Management, LLC 3Y 7Y 0.52% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.31% ORBIMED ADVISORS LLC 3Y 7Y 0.13% ArrowMark Colorado Holdings LLC 3Y 7Y 0.08% Seven Fleet Capital Management LP 0.06% Velan Capital Investment Management LP 3Y 0.03%
← Back to Rangeley Capital, LLC Holdings